Article Text

other Versions

PDF
Challenges in end-of-life dementia care
  1. Anne A Fetherston1,
  2. Grace Rowley2,
  3. Charlotte L Allan3,4
  1. 1Gateshead Health NHS Foundation Trust, Gateshead, UK
  2. 2St Oswald’s Hospice, Gosforth, UK
  3. 3Northumberland Tyne and Wear NHS Foundation Trust, Newcastle University, Newcastle upon Tyne, UK
  4. 4Institute of Neuroscience, Newcastle University, Newcastle, UK
  1. Correspondence to Dr Charlotte L Allan, Centre for the Health of the Elderly, Newcastle upon Tyne NE4 6BE, UK; charlotte.allan{at}ntw.nhs.uk

Abstract

Dementia is a chronic, progressive disease that is now much more widely recognised and treated. Patients with dementia may require palliative care when they reach the end stage of their illness, or they may have mild–moderate cognitive symptoms comorbid with a life-limiting illness. The variety of presentations necessitates a highly individual approach to care planning, and patients should be encouraged to set their own goals and contribute to advanced care planning where possible. Assessment and management of distressing symptoms at the end of life can be greatly helped by a detailed knowledge of the individuals’ prior wishes, interdisciplinary communication and recognition of changes in presentation that may result from new symptoms, for example, onset of pain, nutritional deficits and infection. To navigate complexity at the end of life, open communication that involves patients and families in decisions, and is responsive to their needs is vital and can vastly improve subjective experiences. Complex ethical dilemmas may pervade both the illness of dementia and provision of palliative care; we consider how ethical issues (eg, providing care under restraint) influence complex decisions relating to resuscitation, artificial nutrition and treatment refusal in order to optimise quality of life.

  • mental health

Statistics from Altmetric.com

Footnotes

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.